FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study

被引：0
作者：
Alberto Zaniboni
Enrico Aitini
Sandro Barni
Daris Ferrari
Stefano Cascinu
Vincenzo Catalano
Giuseppe Valmadre
Domenica Ferrara
Enzo Veltri
Claudio Codignola
Roberto Labianca
机构：
[1] Fondazione Poliambulanza,Medical Oncology Unit
[2] C. Poma Hospital,Medical Oncology Unit
[3] Treviglio-Caravaggio Hospital,Medical Oncology Unit
[4] S. Paolo Hospital,Medical Oncology Unit
[5] Università Politecnica delle Marche,Medical Oncology Unit
[6] Ospedali Riuniti di Ancona,Medical Oncology Unit
[7] Ospedali Riuniti Marche Nord,Medical Oncology DH
[8] Presidio San Salvatore,Medical Oncology Unit
[9] Ospedale di Sondalo,Medical Oncology Unit
[10] Ospedale San Carlo,Department of Surgery
[11] Ospedale Don Luigi di Liegro,Medical Oncology Unit
[12] Fondazione Poliambulanza,undefined
[13] Ospedali Riuniti,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Pancreatic cancer; FOLFIRI; Chemotherapy; Second-line; Irinotecan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1641 / 1645
页数：4
相关论文
共 176 条
[71]  
Bachet JB(undefined)undefined undefined undefined undefined-undefined
[72]  
Khemissa-Akouz F(undefined)undefined undefined undefined undefined-undefined
[73]  
Péré-Vergé D(undefined)undefined undefined undefined undefined-undefined
[74]  
Delbaldo C(undefined)undefined undefined undefined undefined-undefined
[75]  
Assenat E(undefined)undefined undefined undefined undefined-undefined
[76]  
Chauffert B(undefined)undefined undefined undefined undefined-undefined
[77]  
Michel P(undefined)undefined undefined undefined undefined-undefined
[78]  
Montoto-Grillot C(undefined)undefined undefined undefined undefined-undefined
[79]  
Ducreux M(undefined)undefined undefined undefined undefined-undefined
[80]  
Ko AH(undefined)undefined undefined undefined undefined-undefined
3456789101112